Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

View source ↗

Summary

A clinical trial is evaluating the safety and efficacy of edoxaban and rivaroxaban for cerebral venous sinus thrombosis in Chinese patients. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Savaysa (edoxaban)
  • Xarelto (rivaroxaban)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Cerebral Venous Thrombosis, Anticoagulants and Thrombotic Disorders | Status: RECRUITING